Potential New Therapeutic Target in Gut Bacteria Linked to Crohn’s Disease

Researchers from Weill Cornell Medicine and New York-Presbyterian report they have discovered a weak spot in the gut bacteria, adherent-invasive Escherichia coli, which may lead to more targeted therapies for Crohn’s disease.